DB
David Baltimore
Co-Founder at Calimmune,
View David's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Co-Founder
Present
Company Details
1 Employees
Calimmune was founded in 2006 based on breakthrough gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies). Calimmune is accelerating the promise of gene therapy to liberate patients from chronic and currently incurable diseases. To achieve our ambitious goal, we have built a suite of technologies to advance the delivery, manufacturing, and overall efficiency of these life-changing medicines. Calimmune's lead development programs are novel ex-vivo gene therapies for hematologic diseases. We are privileged to have some of the world’s most respected gene therapy developers, clinicians, scientific advisors and commercialization experts committed to our mission. We are passionate about what we do, and for those we ultimately seek to serve.
Year Founded
2006
Social Media
Linkedin
Industry
Biotechnology
HQ Location
Greater Los Angeles Area,West Coast,Western US
Keywords
Gene therapyLentiviral vectorsImmune-based therapiesBiotechnologyResearch and DevelopmentInnovatio
Discover More About Cleveland Clinic

Find verified contacts of David Baltimore in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.